Oxytetracycline 250 mg / sulfamethizole 250 mg / phenazopyridine HCl 50 mg Oral Capsule
RxNorm 1094015
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1094015 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: oxytetracycline 250 mg / sulfamethizole 250 mg / phenazopyridine HCl 50 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Oxytetracycline 250 mg / phenazopyridine hydrochloride 50 mg / sulfamethizole 250 mg Oral Capsule
(Atom ID: 12344941)
PSN
Prescribable Name (PSN):
Oxytetracycline 250 mg / sulfamethizole 250 mg / phenazopyridine HCl 50 mg Oral Capsule
(Atom ID: 6366101)
PT
Designated preferred name (PT):
Oxytetracycline hydrochloride 250 mg and phenazopyridine hydrochloride 50 mg and sulfamethizole 250 mg oral capsule
(Atom ID: 10302742)
FN